Author: LMNA Cardiac
ACTION FOR LMNA
A mutation in the lamin A/C gene can lead to serious heart muscle disease. That is why a lot of research is needed to find a new solution. A very involved family, under the leadership of Rogier Veltrop, will help us in an international study set up in Maastricht. This is extraordinary because there are very few family […]
HELP US COMPILE LMNA MEDICAL PROVIDER INFORMATION
Please send your responses to the questions below, via email to info@lmnacardiac.org.We suggest that you copy the questions, paste them and provide responses after each question. Your email address will be kept confidential and will not appear in the document that we are putting together. And, of course, we will not be sharing your email address […]
About LMNA mutations
Mutations in the LMNA gene can cause the lamin A protein to be abnormal, leading to changes in the structure of the nuclear envelope and the way it functions. This can result in several types of LMNA-related heart diseases, including: LMNA-related heart diseases can be inherited in an autosomal dominant pattern, which means that a […]
LMNA patient meeting
The recorded LMNA Patient Meeting (Zoom webinar) is available now. Would you like to receive the latest information and stay up to date on future LMNA Cardiac events? Please sign up for our newsletter to receive updates, news and events. WE NEED YOUR HELP We need your help to get in contact with as many […]
Pfizer to Discontinue Development Program for PF-07265803 for LMNA-Related Dilated Cardiomyopathy
Pfizer Inc. (NYSE: PFE) announced that an interim futility analysis of the global Phase 3 trial, REALM-DCM, designed to evaluate the efficacy and safety of PF-07265803 in patients with symptomatic dilated cardiomyopathy (DCM) due to a mutation of the gene encoding the lamin A/C protein (LMNA), indicated the trial is unlikely to meet its primary […]
DCM Patient and Family Conference (ONLINE) – Recorded version
We are excited to announce the first DCM Patient and Family Conference, organized by the DCM Foundation, bringing hope and education to DCM patients and their family members. This full-day VIRTUAL event will be held from 11:00 AM – 5:00 PM EST and will be broken into 3 segments, each with Live Q&A. One registration […]
DCM Gene Therapy Advancement at Tenaya Therapeutics (Recorded webinar)
WEBINAR Date: July 20th, 2022 – 6:00-7:00 PM ET* (watch the recorded webinar) Details: Join us as we learn about the basics of DCM genetics and the future of DCM gene therapy. This promises to be a very interesting and informative event for all DCM patients and their family members. Topics Include: Date: Wed., July 20th, […]
